Volume 42, Issue 2, Pages (February 2005)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Jung Min Lee, Sang Hoon Ahn, Hyon Suk Kim, Hana Park, Hye Young Chang, Do Young Kim, Seong Gyu Hwang, Kyu Sung Rim, Chae Yoon Chon, Kwang-Hyub Han, and.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Volume 60, Issue 2, Pages (February 2014)
Patients With Autoimmune Hepatitis Who Have Antimitochondrial Antibodies Need Long-term Follow-up to Detect Late Development of Primary Biliary Cirrhosis 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 67, Issue 3, Pages (September 2017)
Volume 50, Issue 4, Pages (April 2009)
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B  Hye Soo Kim, Beom Kyung Kim,
R. Cavallo  Clinical Microbiology and Infection 
Changes in Serologic Markers of Hepatitis B Following Autologous Hematopoietic Stem Cell Transplantation  Ji Eun Uhm, Kihyun Kim, Tae Kyu Lim, Byeong-Bae.
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Kester Crosse, Onuora G. Umeadi, Frank A
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Uchenna H. Iloeje, Hwai–I
Volume 139, Issue 2, Pages (August 2010)
Hepatitis B virus infection: Current status
Stephanos J. Hadziyannis  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Volume 68, Issue 3, Pages (March 2018)
Volume 50, Issue 4, Pages (April 2009)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B  W.-K. Seto, D. K.-H. Wong,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Seizure - European Journal of Epilepsy
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Regression of Hepatic Fibrosis After Intestinal Transplantation in Total Parenteral Nutrition Liver Disease  M. Isabel Fiel, Bernhard Sauter, Hai–Shan.
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Ming-Ling Chang, Yun-Fan Liaw  Journal of Hepatology 
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B  Hye Soo Kim, Beom Kyung Kim,
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 44, Issue 2, Pages (February 2006)
Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients  Eun-Sook Park, Ah Ram Lee, Doo Hyun Kim, Jeong-Hoon.
Volume 42, Issue 4, Pages (April 2005)
Patients With Autoimmune Hepatitis Who Have Antimitochondrial Antibodies Need Long-term Follow-up to Detect Late Development of Primary Biliary Cirrhosis 
Volume 50, Issue 4, Pages (April 2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis  Jin Dong Kim, Jong Young Choi, Si Hyun.
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 67, Issue 5, Pages (November 2017)
Volume 56, Issue 6, Pages (June 2012)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Clinical Gastroenterology and Hepatology
Volume 63, Issue 1, Pages (July 2015)
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
The use of hemospray in portal hypertensive bleeding; a case series
Volume 39, Issue 6, Pages (December 2003)
Chronic hepatitis B in children and adolescents
Volume 62, Issue 3, Pages (March 2015)
Volume 58, Issue 3, Pages (March 2013)
Volume 70, Issue 4, Pages (April 2019)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Reply Journal of Allergy and Clinical Immunology
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Volume 42, Issue 2, Pages 188-194 (February 2005) Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance  Sang Hoon Ahn, Young Nyun Park, Jun Yong Park, Hye-Young Chang, Jung Min Lee, Ji Eun Shin, Kwang-Hyub Han, Chanil Park, Young Myoung Moon, Chae Yoon Chon  Journal of Hepatology  Volume 42, Issue 2, Pages 188-194 (February 2005) DOI: 10.1016/j.jhep.2004.10.026 Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The time from baseline to the follow-up liver biopsy. The closed bars represent the period between the first and the follow-up liver biopsy. The time of HBeAg and HBsAg seroclearance are shown on the bars (▾, HBeAg seroclearance points; ▿, HBsAg seroclearance points). The duration from the time of HBeAg and HBsAg seroclearance to the time of the follow-up liver biopsy is shown at the right side of the figure. Liver biopsy specimens obtained at the end of follow-up were subjected to HBV DNA PCR and histological evaluation. Journal of Hepatology 2005 42, 188-194DOI: (10.1016/j.jhep.2004.10.026) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 2 The first liver biopsy feature of patient 6 showing bridging necrosis and fibrosis (A, B). In second liver biopsy, the necroinflammatory activity is markedly decreased with occasional focal inflammation and apoptosis (C). Fibrosis is also decreased with portal expansion and short fibrous septa (D). (A, H–E ×40; B, C, H–E ×100; D, Masson's trichrome ×100). Journal of Hepatology 2005 42, 188-194DOI: (10.1016/j.jhep.2004.10.026) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions